<DOC>
	<DOCNO>NCT01429155</DOCNO>
	<brief_summary>Hepatitis C lead cause liver transplant USA . Given national organ shortage , live donor liver transplantation become viable option patient end stage liver disease severely ill . Recently particular polymorphism IL-28B gene report correlate histological recurrence antiviral treatment response orthotopic liver transplantation hepatitis C. Similar result describe yet live donor liver transplant patient . There data suggest slightly inferior outcome live donor liver transplant do hepatitis C. The investigator postulate inferior outcome may relate IL28 polymorphism concordance ( i.e. , unfavorable recipient polymorphism patient receive similarly unfavorable polymorphism liver relative ) .</brief_summary>
	<brief_title>Outcomes Hepatitis C After Living Donor Liver Transplantation Association With Interleukin 28 B</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Patients receive live donor liver transplant chronic hepatitis C 18 year old Patients donate part liver patient suffer chronic hepatitis C. Donors must 18 year old Patients willing sign consent Inability obtain liver specimen ( recipient ) Inability obtain blood sample ( donor )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>End stage liver disease</keyword>
	<keyword>Living donor liver transplantation</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>Interleukin 28B</keyword>
</DOC>